FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
about
Zika virus: a new threat to the safety of the blood supply with worldwide impact and implicationsTransfusion practices and infectious risks.A Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.Utilization and quality of cryopreserved red blood cells in transfusion medicine.Why has Borrelia burgdorferi not been transmitted by blood transfusion?Chikungunya virus: new risk to transfusion safety in the Americas.
P2860
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
FDA workshop on emerging infec ...... (EIDs) for transfusion safety.
@en
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases
@nl
type
label
FDA workshop on emerging infec ...... (EIDs) for transfusion safety.
@en
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases
@nl
prefLabel
FDA workshop on emerging infec ...... (EIDs) for transfusion safety.
@en
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases
@nl
P2093
P2860
P1433
P1476
FDA workshop on emerging infec ...... (EIDs) for transfusion safety.
@en
P2093
Chintamani Atreya
Clark Tibbetts
David Asher
Hira Nakhasi
James Hughes
Jay Epstein
Mark Walderhaug
Peter Ganz
Raymond Goodrich
P2860
P304
P356
10.1111/J.1537-2995.2011.03084.X
P577
2011-03-10T00:00:00Z